PyInvesting

Market research

4978.TSE ReproCELL Incorporated

TSE JPY Healthcare

Latest close

105.00 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
10B
P/E ratio
Not available
Analyst target
270
Dividend yield
Not available
Beta
0.58

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

ReproCELL Incorporated is currently in a long term downtrend where the price is trading 16.4% below its 200 day moving average.

From a valuation standpoint, the stock is 67.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.3.

ReproCELL Incorporated's total revenue rose by 2.3% to $334M since the same quarter in the previous year.

Its net income has dropped by 28.3% to $-292M since the same quarter in the previous year.

Based on the above factors, ReproCELL Incorporated gets an overall score of 2/5.